MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Operating Expenses came in at $48.9 million in Q4 2025, down 7.54% YoY from $52.9 million in Q4 2024, and up 5.23% on a QoQ basis from $46.5 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Operating Expenses data on file, last reported at $48.9 million in Q4 2025.
- Quarterly Operating Expenses fell 7.54% year-over-year to $48.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $187.4 million (down 5.13% YoY) and the FY2025 annual result came in at $187.4 million, down 5.13% from the prior year.
- Operating Expenses rose to $48.9 million in Q4 2025, from $46.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $52.9 million in Q4 2024 to a low of $25.6 million in Q2 2021.
- A 5-year average of $38.9 million and a median of $36.8 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 118.16% — and 2025, when it slipped 8.81%.
- Tracing MGTX's Operating Expenses over 5 years: stood at $28.7 million in 2021, then rose by 24.48% to $35.8 million in 2022, then rose by 28.03% to $45.8 million in 2023, then increased by 15.47% to $52.9 million in 2024, then fell by 7.54% to $48.9 million in 2025.
- The last three Operating Expenses figures came in at $48.9 million (Q4 2025), $46.5 million (Q3 2025), and $48.5 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.05 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 960.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 505.13 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.21 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 541.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 427.03 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 77.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.01 Mn |
| Dec 31, 2025 | 48.89 Mn |
| Sep 30, 2025 | 46.46 Mn |
| Jun 30, 2025 | 48.48 Mn |
| Mar 31, 2025 | 43.52 Mn |
| Dec 31, 2024 | 52.88 Mn |
| Sep 30, 2024 | 50.95 Mn |
| Jun 30, 2024 | 46.19 Mn |
| Mar 31, 2024 | 47.47 Mn |
| Dec 31, 2023 | 45.79 Mn |
| Sep 30, 2023 | 37.87 Mn |
| Jun 30, 2023 | 32.33 Mn |
| Mar 31, 2023 | 35.09 Mn |
| Dec 31, 2022 | 35.77 Mn |
| Sep 30, 2022 | 27.62 Mn |
| Jun 30, 2022 | 34.52 Mn |
| Mar 31, 2022 | 34.37 Mn |
| Dec 31, 2021 | 28.73 Mn |
| Sep 30, 2021 | 29.50 Mn |
| Jun 30, 2021 | 25.60 Mn |